Mathes Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Hold
582
0.2% 79
2025
Q4
$625K Hold
582
0.22% 68
2025
Q3
$444K Buy
582
+147
+34% +$109K 0.16% 90
2025
Q2
$339K Sell
435
-510
-54% -$396K 0.13% 104
2025
Q1
$780K Buy
945
+385
+69% +$320K 0.32% 60
2024
Q4
$432K Buy
+560
New +$464K 0.16% 91

Other funds holding LLY

Mathes Company's LLY Position: Q1 2026 in Review

Mathes Company held its Eli Lilly (LLY) position steady in Q1 2026 at 582 shares worth $535K. The position accounts for 0.2% of the portfolio, ranked #79.

Mathes Company first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $780K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mathes Company held 582 shares of Eli Lilly worth $535K as of Q1 2026.
  • Mathes Company left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.2% of Mathes Company's portfolio in Q1 2026, its #79 holding.
  • Mathes Company first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Mathes Company's Eli Lilly position peaked at $780K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.